Results 41 to 50 of about 38,863 (158)

Secondary prevention of coronary heart disease in older patients after the national service framework: population based study [PDF]

open access: yes, 2006
Objective To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework.Design Two population based,
Morris, RW   +15 more
core   +1 more source

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management

open access: yesUniversa Medicina, 2016
Idiopathic thrombocytopenic purpura (ITP) or immune thrombocytopenic purpura is a disease characterized by low platelet count (
Alvina Alvina
doaj   +1 more source

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells

open access: yesInternational Journal of Nanomedicine, 2022
Justyna Hajtuch,1 Eliza Iwicka,1 Anna Szczoczarz,1 Damian Flis,1 Elżbieta Megiel,2 Piotr Cieciórski,2 Marek Witold Radomski,3 Maria Jose Santos-Martinez,4 Iwona Inkielewicz-Stepniak1 1Department of Pharmaceutical Pathophysiology, Medical University ...
Hajtuch J   +8 more
doaj  

Types of antiplatelet agents prescribed to patients who were treated with antiplatelet only or VKA plus antiplatelet.

open access: yes, 2018
Types of antiplatelet agents prescribed to patients who were treated with antiplatelet only or VKA plus antiplatelet.
Ji Hoe Heo (147873)   +14 more
core   +1 more source

The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience

open access: yesFrontiers in Cardiovascular Medicine, 2022
ObjectiveThis study aimed to analyze the characteristics of patients with pericardial effusion requiring pericardiocentesis and to evaluate the safety of pericardiocentesis without discontinuation of anticoagulant or antiplatelet drugs.MethodsWe ...
Yuansong Zhu   +10 more
doaj   +1 more source

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

open access: yes, 2013
The purpose of this pre-specified analysis of the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) was to assess device-specific outcomes relative to different duration of dual antiplatelet therapy ...
TEBALDI, Matteo   +6 more
core   +1 more source

NEW ANTIPLATELET DRUGS. PART 2 [PDF]

open access: yes, 2016
Antiplatelet agents are a necessary component of modern therapy of atherosclerosis. The difficulties of the antiplatelet treatment lie in balance between the necessary therapeutic effect and the risk of excessive action, leads to the bleeding.
A. B. Sumarokov
core   +1 more source

The Role of Antiplatelet agents in ischemic events [PDF]

open access: yes, 2021
Antiplatelet treatment could be a key in pharmacological treatment for avoidance of coronary heart disease (CHD) and stroke. Depending on sign, term of antiplatelet monotherapy or double treatment is shifted.
Baleeqh Uddin, Mohammed   +7 more
core   +1 more source

Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist

open access: yesMolecules, 2016
The P2Y12 receptor is critical for platelet activation and is an attractive drug target for the prevention of atherothrombotic events. Despite the proven antithrombotic efficacy of P2Y12 inhibitors, these thienopyridine scaffolds are prodrugs that lack ...
Young Ha Ahn   +6 more
doaj   +1 more source

Aloanticuerpos contra células sanguíneas en embarazadas nulíparas antes y después de abortos provocados Alloantibodies against blood cells in nuliparous pregnant women before and after induced abortions

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia, 2008
Se realizó un estudio prospectivo para conocer la prevalencia de aloinmunización contra células sanguíneas en 80 mujeres jóvenes nulíparas sin antecedentes de transfusiones sanguíneas ni abortos espontáneos, sometidas a un aborto provocado antes de las ...
María Elena Alfonso Valdés   +8 more
doaj  

Home - About - Disclaimer - Privacy